Loading clinical trials...
Loading clinical trials...
Phase I Clinical Trial to Evaluate the Efficacy of Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions
Conditions
Interventions
Rifampicin
sulforaphane plus rifampicin
+1 more
Locations
2
United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
UW General Clinical Research Center
Seattle, Washington, United States
Start Date
March 1, 2008
Primary Completion Date
June 1, 2010
Completion Date
September 1, 2010
Last Updated
September 6, 2019
Lead Sponsor
University of Washington
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions